Fabio Guolo
24PUBLICATIONS
120CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (24)
Sort by Publication Date:
|Mar 07, 2026
Like a bolt from the blue: the trauma of facing acute leukemia and lymphoma diagnosis and its clinical implications.Fabio Guolo, Paola Del Sette, Francesca Riccardi
|Feb 11, 2026
Intermediate doses cytarabine after induction with CPX-351 for patients with secondary AML: safety and efficacy.Salvatore Perrone, Andrea Corbingi, Calogero Vetro
|Dec 05, 2025
Impact of fitness categorization according to SIE/SIES/GITMO criteria in therapy-related and AML-MRC receiving CPX-351.Raffaele Palmieri, Fabio Guolo, Luana Fianchi
|Sep 24, 2025
Real World Study on the Best CPX-351 Treatment Duration and Timing for Allogeneic Stem Cell Transplantation.Fabio Guolo, Luana Fianchi, Maria Paola Martelli
|Aug 11, 2025
Real World Incidence and Etiology of Infectious Complications in Adults With Ph-Negative Acute Lymphoblastic Leukemia Treated With the Pediatric-Inspired GIMEMA LAL1913 Program. A Campus All Study.Patrizia Zappasodi, Ludovica Calabretta, Virginia Valeria Ferretti
|Mar 06, 2025
Safety run-in and part 1 of GIMEMA AML1718: venetoclax combined with FLAI as induction treatment in non-low-risk AML.Giovanni Marconi, Alfonso Piciocchi, Ernesta Audisio
Pageof 4
Frequent Collaborators
11 joint publications
Paola Minetto
7 joint publications
Marco Cerrano
7 joint publications
Livio Pagano
7 joint publications
Patrizia Chiusolo
7 joint publications
Maria Paola Martelli
7 joint publications
Calogero Vetro
6 joint publications
Adriano Venditti
6 joint publications
Salvatore Perrone
6 joint publications
Giovanni Marconi
5 joint publications
Francesco Grimaldi
